Steris (STE) Liabilities from Discontinued Operations (2023 - 2024)
Steris (STE) posted Liabilities from Discontinued Operations of $64.0 million for Q1 2024, up 26.4% on a QoQ basis from $50.6 million in Q1 2023, and up 26.4% year-over-year from $50.6 million in Q2 2023.
Powered by 
Analysis
Steris (STE) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Steris has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at $64.0 million in Q1 2024.
- On a quarterly basis, Liabilities from Discontinued Operations rose 26.4% year-over-year to $64.0 million in Q1 2024; TTM through Mar 2024 was $64.0 million, a 26.4% increase from a year earlier, with the FY2024 full-year figure at $64.0 million, up 26.4% from the prior year.
- Liabilities from Discontinued Operations was $64.0 million for Q1 2024 at Steris, up from $50.6 million in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was $64.0 million in Q1 2024, with the low at $50.6 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 178.19 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.42 Bn | 119.20 Bn | 1.96 Bn |
| 3 | Medtronic | 118.24 Bn | 109.42 Bn | 6.34 Bn |
| 4 | Stryker | 105.02 Bn | 101.55 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.48 Bn | 65.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.34 Bn | 30.40 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.16 Bn | 17.75 Bn | 1.54 Bn |